Advanced notice from Chairman..... so no complaints again.. Let us show our support to the Management Board and the Company.
Funds raised through the Placement and this Entitlement Offer, if fully subscribed, are intended to be used to fund the Phase IIb/III clinical trial through to futility analysis expected to be completed mid-CY2023.
Should this Entitlement Offer not be fully subscribed, this may lead to a delay in the conduct of the Phase IIb/III study and depending on the amount raised, may require the Company to raise further capital or seek other funding in order to continue and/or complete the study. In this case, the monies raised under this Entitlement Offer may be redeployed to prioritise other key activities including a US Toxicology Study, ATL1102 New Indications, drug manufacture and business development and corporate initiatives to accelerate ATL1102 development plans.
Additionally, funds received by the Company from the exercise of New Options, which are exercisable at any time prior to the Expiry Date, will be primarily used to fund the clinical program through to Phase IIb/III trial results in mid-2024 while also funding the Open Label Extension Study
to the same point.
- Forums
- ASX - By Stock
- PER
- Ann: Prospectus
Ann: Prospectus, page-3
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.1¢ | $47.41K | 578.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 142694 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 104529 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 142694 | 0.081 |
4 | 100252 | 0.080 |
1 | 6500 | 0.079 |
2 | 212658 | 0.078 |
2 | 85000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 104529 | 2 |
0.083 | 214564 | 2 |
0.084 | 67142 | 2 |
0.085 | 90800 | 2 |
0.086 | 106100 | 2 |
Last trade - 14.00pm 12/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |